Substance P in the midbrains of SIDS victims and its correlation with sleep apnea

Toshiko Sawaguchi1, Yuri Ozawa, Franco Patricia

  • 1Department of Legal Medicine, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku, Tokyo 162-8666, Japan. tsawagu@research.twmu.ac.jp

Early Human Development
|December 25, 2003
PubMed

Insights

This study found no link between Substance P levels in the brainstem and sleep apnea in Sudden Infant Death Syndrome (SIDS) cases. These findings do not support a role for Substance P in SIDS pathophysiology related to apnea.

Area of Science:

  • Neuroscience
  • Pediatric Pathology
  • Sleep Medicine

Background:

  • Substance P (SP) is a neuropeptide involved in pain and respiration.
  • Previous reports suggested increased SP in SIDS brains, prompting this investigation.

Purpose of the Study:

  • To investigate the correlation between Substance P and sleep apnea in infants.
  • To determine if SP levels in specific brainstem nuclei are associated with apnea in Sudden Infant Death Syndrome (SIDS).

Main Methods:

  • Prospective study of 27,000 infants, analyzing sleep apnea in 38 deceased infants (26 SIDS).
  • Immunohistochemistry for SP in brainstem nuclei (trigeminal and parabrachial nuclei).
  • Correlation analysis between SP fiber density and sleep apnea frequency/duration.

Main Results:

  • No significant correlation was found between SP fiber density in the studied brainstem regions and the frequency or duration of sleep apnea in SIDS cases.
  • SP levels in the nucleus spinal and mesencephalic nervi trigemini and nucleus parabranchialis were not associated with apnea data.

Conclusions:

  • The study found no significant association between Substance P and apnea data in SIDS.
  • These results contradict the hypothesis linking SP and apnea in the pathophysiology of SIDS.
Abstract